Global Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutics (Intravenous Immunoglobulin, Plasma Exchange, and Others), By Route Of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2023

List of Tables

The Global Guillain-Barre Syndrome Market size is expected to reach $852.2 billion by 2030, rising at a market growth of 4.6% CAGR during the forecast period.

North America, particularly the United States and Canada, has a robust healthcare infrastructure with high healthcare spending levels. Thus, the North America segment captured 36.2% revenue share in the market 2022. According to the Government of Canada, since 2014, approximately half of all cases of AFP that have been identified in Canada have been diagnosed with Guillain-Barre syndrome, and approximately twenty percent of those cases have been diagnosed with transverse myelitis.

GBS primarily affects adults, with the highest incidence rates observed in individuals aged 50 and older. As the global population ages, there's a natural increase in the number of people at risk for GBS, which contributes to the rising prevalence of the condition.

Additionally, according to World Bank data, the World Bank Board of Directors approved US$50 million in new financing for Argentina to improve access to public healthcare services and ensure continued service for 6.5 million residents of the province of Buenos Aires without private health insurance. In conclusion, increasing global healthcare expenditures are driving the market's growth.

However, the acute phase of GBS often requires hospitalization, intensive care, and specialized medical interventions such as plasma exchange and intravenous immunoglobulin (IVIG) therapy. These treatments can incur substantial healthcare costs, including hospital charges, medication expenses, and physician fees, placing financial strain on patients and healthcare systems. Thus, the high cost of treatment is impeding the market's growth.

By Therapeutics Analysis

Based on therapeutics, the market is bifurcated into intravenous immunoglobulin, plasma exchange, and others. In 2022, the intravenous immunoglobulin segment garnered 50.9% revenue share in the market. Intravenous immunoglobulin exerts its therapeutic effects through multiple mechanisms, including modulating immune responses.

By Route Of Administration Analysis

On the basis of the route of administration, the market is segmented into parenteral and oral. In 2022, the oral segment attained a noteworthy revenue share in the market. Oral medications are increasingly utilized for early intervention in GBS cases with mild symptoms or as maintenance therapy following the acute phase of the disease.

By Distribution Channel Analysis

Based on distribution channel, the market is categorized into retail pharmacies, hospital pharmacies, and others. In 2022, the hospital pharmacies segment registered 48.8% revenue share in the market. GBS management typically involves a multidisciplinary team of healthcare professionals, including neurologists, intensivists, physiotherapists, and pharmacists, working together to provide comprehensive patient care.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated 28.2% revenue share in the market. The diagnostic rate of neurological illnesses, including GBS, has improved in the Asia-Pacific region due to increased public and healthcare professional knowledge.

List of Key Companies Profiled

F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
PTC, Inc.
AstraZeneca PLC
Novartis AG
Novo Nordisk A/S
Takeda Pharmaceutical Company Limited
Bayer AG
Merck & Co., Inc.
Bristol Myers Squibb Company

Global Guillain-Barre Syndrome Market Report Segmentation

By Therapeutics

Intravenous Immunoglobulin
Plasma Exchange
Others

By Route Of Administration

Parenteral
Oral

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Global Guillain-Barre Syndrome Market, by Therapeutics
- 1.4.2Global Guillain-Barre Syndrome Market, by Route Of Administration
- 1.4.3Global Guillain-Barre Syndrome Market, by Distribution Channel
- 1.4.4Global Guillain-Barre Syndrome Market, by Geography
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Global Guillain-Barre Syndrome Market by Therapeutics

4.1Global Intravenous Immunoglobulin Market by Region
4.2Global Plasma Exchange Market by Region
4.3Global Others Market by Region

Chapter 5.Global Guillain-Barre Syndrome Market by Route Of Administration

5.1Global Parenteral Market by Region
5.2Global Oral Market by Region

Chapter 6.Global Guillain-Barre Syndrome Market by Distribution Channel

6.1Global Hospital Pharmacies Market by Region
6.2Global Retail Pharmacies Market by Region
6.3Global Others Market by Region

Chapter 7.Global Guillain-Barre Syndrome Market by Region

7.1North America Guillain-Barre Syndrome Market
- 7.1.1North America Guillain-Barre Syndrome Market by Therapeutics
  - 7.1.1.1North America Intravenous Immunoglobulin Market by Country
  - 7.1.1.2North America Plasma Exchange Market by Country
  - 7.1.1.3North America Others Market by Country
- 7.1.2North America Guillain-Barre Syndrome Market by Route Of Administration
  - 7.1.2.1North America Parenteral Market by Country
  - 7.1.2.2North America Oral Market by Country
- 7.1.3North America Guillain-Barre Syndrome Market by Distribution Channel
  - 7.1.3.1North America Hospital Pharmacies Market by Country
  - 7.1.3.2North America Retail Pharmacies Market by Country
  - 7.1.3.3North America Others Market by Country
- 7.1.4North America Guillain-Barre Syndrome Market by Country
  - 7.1.4.1US Guillain-Barre Syndrome Market
    - 7.1.4.1.1US Guillain-Barre Syndrome Market by Therapeutics
    - 7.1.4.1.2US Guillain-Barre Syndrome Market by Route Of Administration
    - 7.1.4.1.3US Guillain-Barre Syndrome Market by Distribution Channel
  - 7.1.4.2Canada Guillain-Barre Syndrome Market
    - 7.1.4.2.1Canada Guillain-Barre Syndrome Market by Therapeutics
    - 7.1.4.2.2Canada Guillain-Barre Syndrome Market by Route Of Administration
    - 7.1.4.2.3Canada Guillain-Barre Syndrome Market by Distribution Channel
  - 7.1.4.3Mexico Guillain-Barre Syndrome Market
    - 7.1.4.3.1Mexico Guillain-Barre Syndrome Market by Therapeutics
    - 7.1.4.3.2Mexico Guillain-Barre Syndrome Market by Route Of Administration
    - 7.1.4.3.3Mexico Guillain-Barre Syndrome Market by Distribution Channel
  - 7.1.4.4Rest of North America Guillain-Barre Syndrome Market
    - 7.1.4.4.1Rest of North America Guillain-Barre Syndrome Market by Therapeutics
    - 7.1.4.4.2Rest of North America Guillain-Barre Syndrome Market by Route Of Administration
    - 7.1.4.4.3Rest of North America Guillain-Barre Syndrome Market by Distribution Channel
7.2Europe Guillain-Barre Syndrome Market
- 7.2.1Europe Guillain-Barre Syndrome Market by Therapeutics
  - 7.2.1.1Europe Intravenous Immunoglobulin Market by Country
  - 7.2.1.2Europe Plasma Exchange Market by Country
  - 7.2.1.3Europe Others Market by Country
- 7.2.2Europe Guillain-Barre Syndrome Market by Route Of Administration
  - 7.2.2.1Europe Parenteral Market by Country
  - 7.2.2.2Europe Oral Market by Country
- 7.2.3Europe Guillain-Barre Syndrome Market by Distribution Channel
  - 7.2.3.1Europe Hospital Pharmacies Market by Country
  - 7.2.3.2Europe Retail Pharmacies Market by Country
  - 7.2.3.3Europe Others Market by Country
- 7.2.4Europe Guillain-Barre Syndrome Market by Country
  - 7.2.4.1Germany Guillain-Barre Syndrome Market
    - 7.2.4.1.1Germany Guillain-Barre Syndrome Market by Therapeutics
    - 7.2.4.1.2Germany Guillain-Barre Syndrome Market by Route Of Administration
    - 7.2.4.1.3Germany Guillain-Barre Syndrome Market by Distribution Channel
  - 7.2.4.2UK Guillain-Barre Syndrome Market
    - 7.2.4.2.1UK Guillain-Barre Syndrome Market by Therapeutics
    - 7.2.4.2.2UK Guillain-Barre Syndrome Market by Route Of Administration
    - 7.2.4.2.3UK Guillain-Barre Syndrome Market by Distribution Channel
  - 7.2.4.3France Guillain-Barre Syndrome Market
    - 7.2.4.3.1France Guillain-Barre Syndrome Market by Therapeutics
    - 7.2.4.3.2France Guillain-Barre Syndrome Market by Route Of Administration
    - 7.2.4.3.3France Guillain-Barre Syndrome Market by Distribution Channel
  - 7.2.4.4Russia Guillain-Barre Syndrome Market
    - 7.2.4.4.1Russia Guillain-Barre Syndrome Market by Therapeutics
    - 7.2.4.4.2Russia Guillain-Barre Syndrome Market by Route Of Administration
    - 7.2.4.4.3Russia Guillain-Barre Syndrome Market by Distribution Channel
  - 7.2.4.5Spain Guillain-Barre Syndrome Market
    - 7.2.4.5.1Spain Guillain-Barre Syndrome Market by Therapeutics
    - 7.2.4.5.2Spain Guillain-Barre Syndrome Market by Route Of Administration
    - 7.2.4.5.3Spain Guillain-Barre Syndrome Market by Distribution Channel
  - 7.2.4.6Italy Guillain-Barre Syndrome Market
    - 7.2.4.6.1Italy Guillain-Barre Syndrome Market by Therapeutics
    - 7.2.4.6.2Italy Guillain-Barre Syndrome Market by Route Of Administration
    - 7.2.4.6.3Italy Guillain-Barre Syndrome Market by Distribution Channel
  - 7.2.4.7Rest of Europe Guillain-Barre Syndrome Market
    - 7.2.4.7.1Rest of Europe Guillain-Barre Syndrome Market by Therapeutics
    - 7.2.4.7.2Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration
    - 7.2.4.7.3Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel
7.3Asia Pacific Guillain-Barre Syndrome Market
- 7.3.1Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
  - 7.3.1.1Asia Pacific Intravenous Immunoglobulin Market by Country
  - 7.3.1.2Asia Pacific Plasma Exchange Market by Country
  - 7.3.1.3Asia Pacific Others Market by Country
- 7.3.2Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
  - 7.3.2.1Asia Pacific Parenteral Market by Country
  - 7.3.2.2Asia Pacific Oral Market by Country
- 7.3.3Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
  - 7.3.3.1Asia Pacific Hospital Pharmacies Market by Country
  - 7.3.3.2Asia Pacific Retail Pharmacies Market by Country
  - 7.3.3.3Asia Pacific Others Market by Country
- 7.3.4Asia Pacific Guillain-Barre Syndrome Market by Country
  - 7.3.4.1China Guillain-Barre Syndrome Market
    - 7.3.4.1.1China Guillain-Barre Syndrome Market by Therapeutics
    - 7.3.4.1.2China Guillain-Barre Syndrome Market by Route Of Administration
    - 7.3.4.1.3China Guillain-Barre Syndrome Market by Distribution Channel
  - 7.3.4.2Japan Guillain-Barre Syndrome Market
    - 7.3.4.2.1Japan Guillain-Barre Syndrome Market by Therapeutics
    - 7.3.4.2.2Japan Guillain-Barre Syndrome Market by Route Of Administration
    - 7.3.4.2.3Japan Guillain-Barre Syndrome Market by Distribution Channel
  - 7.3.4.3India Guillain-Barre Syndrome Market
    - 7.3.4.3.1India Guillain-Barre Syndrome Market by Therapeutics
    - 7.3.4.3.2India Guillain-Barre Syndrome Market by Route Of Administration
    - 7.3.4.3.3India Guillain-Barre Syndrome Market by Distribution Channel
  - 7.3.4.4South Korea Guillain-Barre Syndrome Market
    - 7.3.4.4.1South Korea Guillain-Barre Syndrome Market by Therapeutics
    - 7.3.4.4.2South Korea Guillain-Barre Syndrome Market by Route Of Administration
    - 7.3.4.4.3South Korea Guillain-Barre Syndrome Market by Distribution Channel
  - 7.3.4.5Singapore Guillain-Barre Syndrome Market
    - 7.3.4.5.1Singapore Guillain-Barre Syndrome Market by Therapeutics
    - 7.3.4.5.2Singapore Guillain-Barre Syndrome Market by Route Of Administration
    - 7.3.4.5.3Singapore Guillain-Barre Syndrome Market by Distribution Channel
  - 7.3.4.6Malaysia Guillain-Barre Syndrome Market
    - 7.3.4.6.1Malaysia Guillain-Barre Syndrome Market by Therapeutics
    - 7.3.4.6.2Malaysia Guillain-Barre Syndrome Market by Route Of Administration
    - 7.3.4.6.3Malaysia Guillain-Barre Syndrome Market by Distribution Channel
  - 7.3.4.7Rest of Asia Pacific Guillain-Barre Syndrome Market
    - 7.3.4.7.1Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
    - 7.3.4.7.2Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
    - 7.3.4.7.3Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
7.4LAMEA Guillain-Barre Syndrome Market
- 7.4.1LAMEA Guillain-Barre Syndrome Market by Therapeutics
  - 7.4.1.1LAMEA Intravenous Immunoglobulin Market by Country
  - 7.4.1.2LAMEA Plasma Exchange Market by Country
  - 7.4.1.3LAMEA Others Market by Country
- 7.4.2LAMEA Guillain-Barre Syndrome Market by Route Of Administration
  - 7.4.2.1LAMEA Parenteral Market by Country
  - 7.4.2.2LAMEA Oral Market by Country
- 7.4.3LAMEA Guillain-Barre Syndrome Market by Distribution Channel
  - 7.4.3.1LAMEA Hospital Pharmacies Market by Country
  - 7.4.3.2LAMEA Retail Pharmacies Market by Country
  - 7.4.3.3LAMEA Others Market by Country
- 7.4.4LAMEA Guillain-Barre Syndrome Market by Country
  - 7.4.4.1Brazil Guillain-Barre Syndrome Market
    - 7.4.4.1.1Brazil Guillain-Barre Syndrome Market by Therapeutics
    - 7.4.4.1.2Brazil Guillain-Barre Syndrome Market by Route Of Administration
    - 7.4.4.1.3Brazil Guillain-Barre Syndrome Market by Distribution Channel
  - 7.4.4.2Argentina Guillain-Barre Syndrome Market
    - 7.4.4.2.1Argentina Guillain-Barre Syndrome Market by Therapeutics
    - 7.4.4.2.2Argentina Guillain-Barre Syndrome Market by Route Of Administration
    - 7.4.4.2.3Argentina Guillain-Barre Syndrome Market by Distribution Channel
  - 7.4.4.3UAE Guillain-Barre Syndrome Market
    - 7.4.4.3.1UAE Guillain-Barre Syndrome Market by Therapeutics
    - 7.4.4.3.2UAE Guillain-Barre Syndrome Market by Route Of Administration
    - 7.4.4.3.3UAE Guillain-Barre Syndrome Market by Distribution Channel
  - 7.4.4.4Saudi Arabia Guillain-Barre Syndrome Market
    - 7.4.4.4.1Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics
    - 7.4.4.4.2Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration
    - 7.4.4.4.3Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel
  - 7.4.4.5South Africa Guillain-Barre Syndrome Market
    - 7.4.4.5.1South Africa Guillain-Barre Syndrome Market by Therapeutics
    - 7.4.4.5.2South Africa Guillain-Barre Syndrome Market by Route Of Administration
    - 7.4.4.5.3South Africa Guillain-Barre Syndrome Market by Distribution Channel
  - 7.4.4.6Nigeria Guillain-Barre Syndrome Market
    - 7.4.4.6.1Nigeria Guillain-Barre Syndrome Market by Therapeutics
    - 7.4.4.6.2Nigeria Guillain-Barre Syndrome Market by Route Of Administration
    - 7.4.4.6.3Nigeria Guillain-Barre Syndrome Market by Distribution Channel
  - 7.4.4.7Rest of LAMEA Guillain-Barre Syndrome Market
    - 7.4.4.7.1Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics
    - 7.4.4.7.2Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration
    - 7.4.4.7.3Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel

Chapter 8.Company Profiles

8.1F. Hoffmann-La Roche Ltd.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Pfizer, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional & Segmental Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
8.3PTC, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5SWOT Analysis
8.4AstraZeneca PLC
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional Analysis
- 8.4.4Research & Development Expenses
- 8.4.5SWOT Analysis
8.5Novartis AG
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5Recent strategies and developments:
  - 8.5.5.1Partnerships, Collaborations, and Agreements:
- 8.5.6SWOT Analysis
8.6Novo Nordisk A/S
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental and Regional Analysis
- 8.6.4Research & Development Expenses
- 8.6.5SWOT Analysis
8.7Takeda Pharmaceutical Company Limited
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Bayer AG
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5SWOT Analysis
8.9Merck & Co., Inc.
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5Recent strategies and developments:
  - 8.9.5.1Partnerships, Collaborations, and Agreements:
- 8.9.6SWOT Analysis
8.10.Bristol Myers Squibb Company
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

Chapter 9.Winning Imperatives of Guillain-Barre Syndrome Market

LIST OF TABLES

TABLE 1Global Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 2Global Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 3Global Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 4Global Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 5Global Intravenous Immunoglobulin Market by Region, 2019 - 2022, USD Thousands
TABLE 6Global Intravenous Immunoglobulin Market by Region, 2023 - 2030, USD Thousands
TABLE 7Global Plasma Exchange Market by Region, 2019 - 2022, USD Thousands
TABLE 8Global Plasma Exchange Market by Region, 2023 - 2030, USD Thousands
TABLE 9Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 10Global Others Market by Region, 2023 - 2030, USD Thousands
TABLE 11Global Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 12Global Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 13Global Parenteral Market by Region, 2019 - 2022, USD Thousands
TABLE 14Global Parenteral Market by Region, 2023 - 2030, USD Thousands
TABLE 15Global Oral Market by Region, 2019 - 2022, USD Thousands
TABLE 16Global Oral Market by Region, 2023 - 2030, USD Thousands
TABLE 17Global Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 18Global Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 19Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Thousands
TABLE 20Global Hospital Pharmacies Market by Region, 2023 - 2030, USD Thousands
TABLE 21Global Retail Pharmacies Market by Region, 2019 - 2022, USD Thousands
TABLE 22Global Retail Pharmacies Market by Region, 2023 - 2030, USD Thousands
TABLE 23Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 24Global Others Market by Region, 2023 - 2030, USD Thousands
TABLE 25Global Guillain-Barre Syndrome Market by Region, 2019 - 2022, USD Thousands
TABLE 26Global Guillain-Barre Syndrome Market by Region, 2023 - 2030, USD Thousands
TABLE 27North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 28North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 29North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 30North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 31North America Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 32North America Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 33North America Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 34North America Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 35North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 36North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 37North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 38North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 39North America Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 40North America Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 41North America Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 42North America Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 43North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 44North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 45North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 46North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 47North America Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 48North America Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 49North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 50North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 51North America Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 52North America Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 53US Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 54US Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 55US Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 56US Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 57US Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 58US Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 59US Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 60US Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 61Canada Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 62Canada Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 63Canada Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 64Canada Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 65Canada Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 66Canada Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 67Canada Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 68Canada Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 69Mexico Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 70Mexico Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 71Mexico Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 72Mexico Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 73Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 74Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 75Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 76Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 77Rest of North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 78Rest of North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 79Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 80Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 81Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 82Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 83Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 84Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 85Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 86Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 87Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 88Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 89Europe Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 90Europe Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 91Europe Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 92Europe Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 93Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 94Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 95Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 96Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 97Europe Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 98Europe Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 99Europe Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 100Europe Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 101Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 102Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 103Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 104Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 105Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 106Europe Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 107Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 108Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 109Europe Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 110Europe Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 111Germany Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 112Germany Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 113Germany Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 114Germany Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 115Germany Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 116Germany Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 117Germany Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 118Germany Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 119UK Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 120UK Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 121UK Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 122UK Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 123UK Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 124UK Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 125UK Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 126UK Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 127France Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 128France Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 129France Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 130France Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 131France Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 132France Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 133France Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 134France Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 135Russia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 136Russia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 137Russia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 138Russia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 139Russia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 140Russia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 141Russia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 142Russia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 143Spain Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 144Spain Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 145Spain Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 146Spain Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 147Spain Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 148Spain Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 149Spain Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 150Spain Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 151Italy Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 152Italy Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 153Italy Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 154Italy Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 155Italy Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 156Italy Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 157Italy Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 158Italy Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 159Rest of Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 160Rest of Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 161Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 162Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 163Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 164Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 165Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 166Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 167Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 168Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 169Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 170Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 171Asia Pacific Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 172Asia Pacific Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 173Asia Pacific Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 174Asia Pacific Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 175Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 176Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
TABLE 177Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 178Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 179Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 180Asia Pacific Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 181Asia Pacific Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 182Asia Pacific Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 183Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 184Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 185Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 186Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 187Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 188Asia Pacific Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 189Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 190Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
TABLE 191Asia Pacific Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 192Asia Pacific Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 193China Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 194China Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 195China Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 196China Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 197China Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 198China Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 199China Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 200China Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 201Japan Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 202Japan Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 203Japan Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 204Japan Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 205Japan Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 206Japan Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 207Japan Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 208Japan Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 209India Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 210India Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 211India Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 212India Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 213India Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 214India Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 215India Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 216India Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands

TABLE 217South Korea Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 218South Korea Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 219South Korea Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 220South Korea Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 221South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 222South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 223South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 224South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 225Singapore Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 226Singapore Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 227Singapore Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 228Singapore Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 229Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 230Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 231Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 232Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 233Malaysia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 234Malaysia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 235Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 236Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 237Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 238Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 239Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 240Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 241Rest of Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 242Rest of Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 243Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 244Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 245Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 246Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 247Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 248Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 249LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 250LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 251LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 252LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 253LAMEA Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 254LAMEA Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 255LAMEA Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 256LAMEA Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 257LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 258LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 259LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 260LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 261LAMEA Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 262LAMEA Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 263LAMEA Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 264LAMEA Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 265LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 266LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 267LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 268LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 269LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 270LAMEA Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 271LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 272LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 273LAMEA Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 274LAMEA Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 275Brazil Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 276Brazil Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 277Brazil Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 278Brazil Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 279Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 280Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 281Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 282Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 283Argentina Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 284Argentina Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 285Argentina Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 286Argentina Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 287Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 288Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 289Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 290Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 291UAE Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 292UAE Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 293UAE Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 294UAE Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 295UAE Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 296UAE Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 297UAE Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 298UAE Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 299Saudi Arabia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 300Saudi Arabia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 301Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 302Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 303Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 304Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 305Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 306Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 307South Africa Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 308South Africa Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 309South Africa Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 310South Africa Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 311South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 312South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 313South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 314South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 315Nigeria Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 316Nigeria Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 317Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 318Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 319Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 320Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 321Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 322Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 323Rest of LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 324Rest of LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 325Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 326Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 327Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 328Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 329Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 330Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 331Key Information - F. Hoffmann-La Roche Ltd.
TABLE 332Key Information - Pfizer, Inc.
TABLE 333key Information - PTC, Inc.
TABLE 334KEY INFORMATION - AstraZeneca PLC
TABLE 335Key Information - Novartis AG
TABLE 336Key Information - Novo Nordisk A/S
TABLE 337Key Information - Takeda Pharmaceutical Company Limited
TABLE 338Key Information - Bayer AG
TABLE 339Key Information - Merck & Co., Inc.
TABLE 340Key Information - Bristol Myers Squibb Company

Global Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutics (Intravenous Immunoglobulin, Plasma Exchange, and Others), By Route Of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

Description

Table of Contents